Evidence map›Paper›PMID 35764649›Full record

ArticleNature communications2022

Senescent cells limit p53 activity via multiple mechanisms to remain viable.

Ines Sturmlechner, Chance C Sine, Karthik B Jeganathan, Cheng Zhang, Raul O Fierro Velasco, Darren J Baker, Hu Li, Jan M van Deursen

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. CHK2-USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Histone modification clocks for robust cross-species biological age prediction and elucidating senescence regulation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. The impact of cellular senescence on aging skeletal muscle.Frontiers in cell and developmental biology · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Ines SturmlechnerDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-1272-5618
Chance C SineDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Karthik B JeganathanDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Cheng ZhangDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Raul O Fierro VelascoDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-4889-128X
Darren J BakerDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-9006-1939
Hu LiDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5957-5472
Jan M van DeursenDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA. janvandeursen2@gmail.com.ORCID 0000-0002-3042-5267
Mayo Clinic · USMayo Clinic in Florida · USMayo Clinic in Arizona · USUniversity Medical Center Groningen · NL

Funding

BUBRI in Normal and Neoplastic GrowthR01CA096985 · NCI · MAYO CLINIC ROCHESTER · PI BAKER, DARREN · 2002 to 2022
$6.2M
Capturing the molecular complexity of Alzheimer's disease through the lens of RNA binding proteinsRF1AG056318 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LI, HU, WOLOZIN, BENJAMIN L · 2018 to 2020
$4.4M
Cellular senescence in aging and age-related disease (Supplement application)R01AG057493 · NIA · MAYO CLINIC ROCHESTER · PI BRAM, RICHARD J · 2018 to 2022
$1.9M
NCI NIH HHS R01 CA096985NIA NIH HHS R01 AG057493NIA NIH HHS RF1 AG056318
6 · The paper itself

Abstract

Super-enhancers regulate genes with important functions in processes that are cell type-specific or define cell identity. Mouse embryonic fibroblasts establish 40 senescence-associated super-enhancers regardless of how they become senescent, with 50 activated genes located in the vicinity of these enhancers. Here we show, through gene knockdown and analysis of three core biological properties of senescent cells that a relatively large number of senescence-associated super-enhancer-regulated genes promote survival of senescent mouse embryonic fibroblasts. Of these, Mdm2, Rnase4, and Ang act by suppressing p53-mediated apoptosis through various mechanisms that are also engaged in response to DNA damage. MDM2 and RNASE4 transcription is also elevated in human senescent fibroblasts to restrain p53 and promote survival. These insights identify key survival mechanisms of senescent cells and provide molecular entry points for the development of targeted therapeutics that eliminate senescent cells at sites of pathology.

Indexed as

FibroblastsTumor Suppressor Protein p53AnimalsApoptosisCellular SenescenceDNA DamageMiceTumor Suppressor Protein p53

Identifiers

PMID35764649
PMCPMC9240076
OpenAlexW4283655546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.